214603-97-1 Purity
---
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1]Akai, Shuji; Tsujino, Toshiaki; Naka, Tadaatsu; Tanimoto, Kouichi; Kita, Yasuyuki
[Tetrahedron Letters, 2001, vol. 42, # 41, p. 7315 - 7317]
Reference: [1] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 2, p. 94 - 97
Reference: [1]Akai, Shuji; Tsujino, Toshiaki; Naka, Tadaatsu; Tanimoto, Kouichi; Kita, Yasuyuki
[Tetrahedron Letters, 2001, vol. 42, # 41, p. 7315 - 7317]
[2]Akai, Shuji; Tsujino, Toshiaki; Akiyama, Emi; Tanimoto, Kouichi; Naka, Tadaatsu; Kita, Yasuyuki
[Journal of Organic Chemistry, 2004, vol. 69, # 7, p. 2478 - 2486]
[3]Shi, Weihua; Jiang, Zhigan; He, Haiying; Xiao, Fubiao; Lin, Fusen; Sun, Ya; Hou, Lijuan; Shen, Liang; Han, Lixia; Zeng, Minggao; Lai, Kunmin; Gu, Zhengxian; Chen, Xinsheng; Zhao, Tao; Guo, Li; Yang, Chun; Li, Jian; Chen, Shuhui
[ACS Medicinal Chemistry Letters, 2018, vol. 9, # 2, p. 94 - 97]
Reference: [1]Moody, Christopher J.; Slawin, Alexandra M.Z.; Willows, David
[Organic and Biomolecular Chemistry, 2003, vol. 1, # 15, p. 2716 - 2722]
[2]Koshizawa, Tomoaki; Morimoto, Toshiharu; Watanabe, Gen; Watanabe, Toshiaki; Yamasaki, Nao; Sawada, Yoshikazu; Fukuda, Tomoaki; Okuda, Ayumu; Shibuya, Kimiyuki; Ohgiya, Tadaaki
[Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 15, p. 3249 - 3253]
[3]Current Patent Assignee: ALEMBIC PHARMACEUTICALS LIMITED - WO2021/220120, 2021, A1
Location in patent: Paragraph 215
[4]Li, Honghe; Yan, Xiaoqiang; Zhang, Jitan; Guo, Weicong; Jiang, Jijun; Wang, Jun
[Angewandte Chemie - International Edition, 2019, vol. 58, # 20, p. 6732 - 6736][Angew. Chem., 2019, vol. 131, # 20, p. 6804 - 6808,5]
[5]Current Patent Assignee: CSPC PHARMACEUTICAL GROUP LIMITED - EP3632910, 2020, A1
Location in patent: Paragraph 0231
* For details of the synthesis route, please refer to the original source to ensure accuracy.